| Literature DB >> 28337452 |
C R Silva1, K S N Marinho2, T D S Silva1, D K S Ferreira3, G M Aguiar3, M C B Martins1, K R P Santos3, F C A Aguiar Júnior3, N P S Santos3, E C Pereira4, N H Silva1.
Abstract
Studies about toxicological potential of usnic acid are limited. This way, the vast majority of data available in the literature are related only to biological activities. This is the first study that aimed to evaluate the oral toxicity of usnic acid during the period of organogenesis. Females rats were distributed in the control groups, treated I and II, at doses of 15 and 25 mg/kg, administered by gavage during the 6° to 15° days of pregnancy. After 20 days the fetuses were removed and analyzed. A reduction in weight gain during pregnancy, increased resorption, reduction in the number of viable fetuses, and their body weight were observed. Morphological changes in the litter were visualized as exposure of the eye and atrophy of the limbs at the dose of 25 mg/kg. Histological analysis of the liver of the fetus showed reduction in the number of megakaryocytes between experimental groups and increase in the number of hepatocytes in a dose of 25 mg/kg. The experimental model used in this study reveals teratogenic effect of usnic acid in the period of organogenesis. Since this achievement, the importance of evaluating the toxic effects of natural substances is imperative, in order to elucidate the care in their indication as drug.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28337452 PMCID: PMC5350305 DOI: 10.1155/2017/5948936
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Scientific research on biological activity and toxicity of usnic acid. Source: Scopus.
Figure 2Calibration line of purified usnic acid from Cladonia substellata.
Reproductive variables attributed to pregnant rats.
| Groups | |||
|---|---|---|---|
| G1 | G2 | G3 | |
| Mean body weight (g) | |||
| Day 0 | 208 ± 4.3 | 209 ± 5.6 | 208 ± 5.2 |
| Day 6 | 227 ± 1.4 | 227 ± 3.1 | 226 ± 5.8 |
| Day 10 | 255 ± 3.4 | 236 ± 3.8 | 224 ± 5.8 |
| Day 14 | 276 ± 2.3 | 250 ± 2.8 | 229 ± 6.9 |
| Day 20 | 299 ± 2.5 | 279 ± 3.6 | 247 ± 6.6 |
| Number of implantations | 12 ± 0.5 | 10 ± 1.0 | 8 ± 1.4 |
| Number of resorptions | 1.1 ± 0.4 | 3.5 ± 0.5 | 5.0 ± 1.0 |
Data are expressed as mean ± standard deviation. ANOVA-Tukey. P < 0.05, P < 0.001 compared to the control group.
Figure 3Fetuses obtained from experimental and control groups and treated at 25 mg/kg: (a) Control group, (b) treated group at 25 mg/kg. Arrows showing embryos with interruption in the development and tiny placentas, (c) treated at 25 mg/kg presenting reduction in the number of viable fetuses.
Parameters of prole.
| Groups | |||
|---|---|---|---|
| G1 | G2 | G3 | |
| Mean body weight (g) | 5.7 ± 0.3 | 4.6 ± 0.1 | 3.5 ± 0.1 |
| Liver weight | 0.5 ± 0.02 | 0.3 ± 0.02 | 0.2 ± 0.05 |
Data are expressed as mean ± standard deviation. ANOVA-Tukey. P < 0.05, P < 0.001 compared to the control group.
Figure 4Fetus obtained from female treated with purified usnic acid at 25 mg/kg presenting interruption in embryonic development: (a) mass developing and (b) placenta.
Figure 5Malformations in fetuses obtained from treated females with purified usnic acid at 25 mg/kg: (a) Arrow showing protrusion of the eyeball, (b) Arrow showing cell mass in the upper region of the fetus, (c) Arrows showing atrophy of the upper and lower limbs.
Histomorphometric analysis of the liver of pregnant rats treated with usnic acid.
| Groups | |||
|---|---|---|---|
| G1 | G2 | G3 | |
| NH | 90.44 ± 15,61 | 109.38 ± 16,02 | 116.96 ± 12.67 |
| NCK | 3.26 ± 2.26 | 4.03 ± 2.62 | 5 ± 2.83 |
NH: number of hepatocytes; NCK: number of Kupffer cells. Data are expressed as mean ± standard deviation. ANOVA-Tukey. P < 0.05, P < 0.001 compared to the control group.
Histomorphometric analysis of the liver of the fetus from rats treated with usnic acid during pregnancy.
| Groups | |||
|---|---|---|---|
| G1 | G2 | G3 | |
| NH | 33.4 ± 8.6 | 33.2 ± 9.9 | 41.6 ± 6.0 |
| NM | 0.17 ± 0.01 | 0.12 ± 0.01 | 0.08 ± 0.01 |
NH: number of hepatocytes; NM: number of megakaryocytes. Data are expressed as mean ± standard deviation. ANOVA-Tukey. P < 0.05, P < 0.001 compared to the control group.